Evidence map›Paper›PMID 42132967›Full record

ArticleEpilepsia2026

Pyruvate dehydrogenase autoantibodies in autoantibody-negative patients with seizures are associated with reduced pyruvate dehydrogenase activity.

Annika Breuer, Chiara A Hummel, Tobias Baumgartner, Juliane L Berns, Afaf Milad Said, Isabel Bünger, Susanne Schoch, Gábor Zsurka, Harald Prüss, Wolfram S Kunz and 3 more

Abstract read
In one paragraph

Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Annika BreuerDepartment of Epileptology, University Hospital Bonn, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0009-0005-2401-0013
Chiara A HummelDepartment of Epileptology, University Hospital Bonn, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0009-0009-1276-5223
Tobias BaumgartnerDepartment of Epileptology, University Hospital Bonn, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0000-0001-5935-9841
Juliane L BernsDepartment of Epileptology, University Hospital Bonn, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0009-0002-5003-4922
Afaf Milad SaidInstitute of Experimental Epileptology and Cognition Research, University Hospital Bonn, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0009-0002-7922-6952
Isabel BüngerDepartment of Pediatric Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0001-8845-2447
Susanne SchochDepartment of Epileptology, University Hospital Bonn, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0000-0002-2046-2670
Gábor ZsurkaDepartment of Epileptology, University Hospital Bonn, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0000-0002-6379-849X
Harald PrüssDepartment of Neurology and Experimental Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-8283-7976
Wolfram S KunzDepartment of Epileptology, University Hospital Bonn, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0000-0003-1113-3493
Rainer SurgesDepartment of Epileptology, University Hospital Bonn, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0000-0002-3177-8582
Albert J BeckerDepartment of Pediatric Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-2661-3705
Julika PitschDepartment of Epileptology, University Hospital Bonn, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0000-0002-6688-4916

Funding

BONFOR/SciMed program of the Medical Faculty, University of BonnDeutsche Forschungsgemeinschaft FOR 2715Deutsche Forschungsgemeinschaft PI 1931/2-1Deutsche Forschungsgemeinschaft SCHO 820Deutsche Forschungsgemeinschaft SCHO 820/6-2Deutsche Forschungsgemeinschaft SCHO 820/7-1Deutsche Forschungsgemeinschaft SCHO 820/8-1Deutsche Forschungsgemeinschaft SFB1089Deutsche Forschungsgemeinschaft SPP1757Katholischer Akademischer Ausländer-DienstMinisterium für Kultur und Wissenschaft des Landes Nordrhein-WestfalenWilhelm Sander-Stiftung 2023.107.1
6 · The paper itself

Abstract

objectiveWe investigated the presence and potential functional relevance of antimitochondrial autoantibodies in patients suspicious for autoimmune encephalitis (AIE) associated with psychiatric symptoms and/or seizures, who were negative for known antineuronal autoantibodies.

methodsWe screened serum samples from 387 patients autoantibody-negative for known antineuronal autoantibodies with psychiatric disturbances and/or epileptic seizures, including patients with temporal lobe epilepsy of unknown etiology. Various techniques, including immunoblotting, immunoprecipitation, mass spectrometry, immunohistochemistry, and in vitro assays assessing neuronal autoantibody uptake, neuronal viability, pyruvate dehydrogenase (PDH) enzyme activity, and mitochondrial DNA levels in biofluids were applied.

resultsMass spectrometry detected all three subunits of the intramitochondrial PDHc-pyruvate dehydrogenase, dihydrolipoyl acetyltransferase, and dihydrolipoyl dehydrogenase-as targets of antibodies present in serum samples from three index patients suspicious for AIE with psychiatric symptoms or seizures. The presence of the anti-PDHc autoantibodies was confirmed by immunoblotting in 12 of 387 patients. Exposure of cultured primary neurons to commercial anti-PDH antibodies resulted in neuronal uptake and loss of neuronal viability. Patient-derived autoantibodies also impaired PDH enzyme activity in vitro. Additionally, cell-free mitochondrial DNA fragment levels were elevated in the serum and cerebrospinal fluid of PDH-positive patients compared to controls. SIGNIFICANCE: Anti-PDH autoantibodies were detected in patients suspicious for AIE with seizures and/or psychiatric symptoms as core manifestation in the absence of known antineuronal autoantibodies. These autoantibodies bind neuronal structures and reduce PDH enzyme activity under experimental conditions, supporting mechanistic plausibility of a functional role in disease.

Indexed as

AutoantibodiesEncephalitisPyruvate Dehydrogenase ComplexSeizuresAdolescentAdultAgedDNA, MitochondrialFemaleHumansMaleMiddle AgedNeuronsYoung AdultAutoantibodiesDNA, MitochondrialPyruvate Dehydrogenase Complexantimitochondrial autoantibodiesenzyme activitymitochondriapsychiatric symptomsseizures

Identifiers

PMID42132967
PMCPMC13525559

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.